Open Now: The Global ETF Survey Take the Survey →
iShares U.S. Pharmaceuticals ETF
IHE performance and flow charts
Performance
Flows
Historic performance and flows
Data as of July 24, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +7.79% | +19.43% | +21.58% | +50.57% | +77.09% | +76.59% |
| Flows | +$506M | +$460M | +$541M | +$695M | +$790M | +$805M |
Characteristics
The iShares U.S. Pharmaceuticals ETF is built to track the Dow Jones U.S. Select Pharmaceuticals Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | iShares |
| N° of holdings | 57 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | May 1, 2006 |
| ESG | No |
More data and info about IHE on Trackinsight
Exposure
Data as of June 30, 2026Diversification
Total weight of top 15 holdings out of 57
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +21.18% | +18.07% | +16.90% | +16.50% |
Max drawdown | -4.42% | -8.48% | -16.04% | -16.12% |
Max drawdown duration | 17d | 81d | 210d | 669d |
Time to recover | N/A | 56d | 173d | 484d |
Replication quality
Data as of June 30, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is IHE?
IHE is a Passive ETF that provides exposure to Equity assets. It is managed by iShares.
What index does IHE track?
IHE tracks the Dow Jones U.S. Select Pharmaceuticals Total Return Index - USD, aiming to replicate its performance through optimized sampling.
What does IHE invest in?
This ETF provides exposure to US Pharmaceuticals Equities. It is part of the segment: US Health Care.
What is the expense ratio of IHE?
The total expense ratio (TER) of IHE is 0.38%, representing the annual fee charged by the fund manager.
When was IHE launched?
IHE was launched on May 1, 2006, marking its entry into the ETF market.
Who is the issuer of IHE?
IHE is issued by iShares.
What is the AUM of IHE?
As of July 24, 2026, IHE manages $1.58 B, reflecting the total assets held in the fund.
How has IHE performed recently?
As of July 24, 2026, IHE delivered a return of 7.79% over the past month (1M performance), 19.43% over the past three months (3M), and 21.58% year-to-date (YTD).
What are the recent fund flows for IHE?
As of July 24, 2026, IHE has seen net flows of +$506M in the past month (1M flow) and +$541M year-to-date (YTD).
Does IHE pay dividends?
As of July 24, 2026, IHE has a trailing 12-month distribution yield of 1.43%.
How many holdings are in IHE
As of June 30, 2026, IHE holds 57 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is IHE?
As of June 30, 2026, IHE holds 57 securities, with 84.53% of its assets concentrated in its top 15 holdings.
What are the top holdings of IHE?
As of June 30, 2026, IHE holds a portfolio of 57 underlyings, with its largest positions including Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does IHE invest in?
As of June 30, 2026, IHE has its largest geographic exposures in USA.
What sectors or themes does IHE focus on?
As of June 30, 2026, IHE is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
ETF Trends
ETF Industry KPIs July 20, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs July 13, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
First Look ETF
First Look ETF: Cash Deployment, Bond, and Hedged ETFs
In this season 6 episode of First Look ETF, Stephanie Stanton examines the latest ETF marketplace trends with NYSE and guests.
ETF Trends
ETF Industry KPIs July 6, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
Browse all educational columns
The ETF Industry Is Evolving Fast
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.
